Obesity and Maternal Weight Gain
1Human Nutrition, University of Glasgow, Level 2, New Lister Building, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK. Catherine.Hankey@glasgow.ac.uk.
Current Obesity Reports
|December 3, 2015
Summary
Interventions to manage body weight in obese pregnant women show limited success. More robust and effective strategies are needed for routine clinical practice to address this growing concern.
Area of Science:
- Maternal health
- Obesity research
- Public health interventions
Background:
- Rising prevalence of obesity in adults, including pregnant women.
- Obesity in pregnancy linked to adverse maternal and infant outcomes, including excessive gestational weight gain.
- Pregnancy presents a "teachable moment" for health interventions.
Purpose of the Study:
- To review evidence on interventions for body weight management in obese and overweight pregnant women.
- To assess the effectiveness of pre- and post-natal interventions on body weight and pregnancy outcomes.
- To identify gaps in current clinical practice regarding weight management during and after pregnancy.
Main Methods:
- Systematic review of lifestyle interventions targeting diet and physical activity.
- Analysis of studies assessing pre-natal, post-natal, and combined interventions.
- Evaluation of intervention success in reducing body weight and gestational weight gain.
Main Results:
- Some lifestyle interventions show promise but have limited success in pre- and post-natal weight reduction.
- Minimizing excessive gestational weight gain during pregnancy has shown limited effectiveness.
- Current interventions are not robust or effective enough for routine clinical practice.
Conclusions:
- Weight management interventions for obese pregnant women require further development for clinical application.
- Pre- and post-natal weight management is largely overlooked in standard maternal care.
- There is a need for more effective and robust strategies to address obesity in pregnancy.
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
339
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
339
Pathophysiology of Diabetes
4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Diabetes Mellitus: Type 2 and Gestational
5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
281
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281


